Akshay Kharat

5PUBLICATIONS
13CO-AUTHORS
Gene and molecular therapyAutonomic nervous systemCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 03, 2025
Healthcare resource utilization and costs in patients with multiple myeloma who received 1 to 3 prior lines of therapy, including a proteasome inhibitor and an immunomodulatory drug, and were exposed to and discontinued lenalidomide in the United States.

Sundar Jagannath, Akshay Kharat, Eric Chinaeke

|Jan 10, 2025
Health Care Resource Use and Costs of Rivaroxaban Versus Warfarin Among Nonvalvular Atrial Fibrillation Polypharmacy Patients With Obesity.

Mark Alberts, Jinghua He, Akshay Kharat

|Apr 04, 2023
Component Costs of CAR-T Therapy in Addition to Treatment Acquisition Costs in Patients with Multiple Myeloma.

Sundar Jagannath, Nedra Joseph, Concetta Crivera

|Oct 13, 2021
Combination anticoagulant or P2Y12 inhibitor with low-dose aspirin versus low-dose aspirin alone in patients at risk or with documented coronary and/or peripheral artery disease.

Craig I Coleman, Akshay A Kharat, Brahim Bookhart

|Feb 26, 2021
Healthcare resource utilization and costs of major atherothrombotic vascular events among patients with peripheral artery disease after revascularization.

Urvi Desai, Akshay Kharat, Connie N Hess

Pageof 1

Frequent Collaborators

1 joint publications

Craig I Coleman

1 joint publications

William L Baker

1 joint publications

Urvi Desai

1 joint publications

François Laliberté